BIOGEN IDEC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOGEN IDEC, and when can generic versions of BIOGEN IDEC drugs launch?
BIOGEN IDEC has one approved drug.
There are nine US patents protecting BIOGEN IDEC drugs.
There are eighty patent family members on BIOGEN IDEC drugs in twenty-seven countries and twenty-five supplementary protection certificates in eighteen countries.
Summary for BIOGEN IDEC
| International Patents: | 80 |
| US Patents: | 9 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| PTAB Cases with BIOGEN IDEC as patent owner: | See PTAB cases with BIOGEN IDEC as patent owner |
Drugs and US Patents for BIOGEN IDEC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | RX | Yes | Yes | 10,266,822 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | RX | Yes | Yes | 8,980,853 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | RX | Yes | Yes | 8,361,977 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | RX | Yes | Yes | 7,838,657 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | RX | Yes | Yes | 12,013,403 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | RX | Yes | Yes | 8,110,560 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | RX | Yes | Yes | 9,717,750 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BIOGEN IDEC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | 6,166,197 | ⤷ Subscribe |
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | 6,210,892 | ⤷ Subscribe |
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | 7,101,993 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BIOGEN IDEC Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20220084437 | ⤷ Subscribe |
| Hong Kong | 1246648 | ⤷ Subscribe |
| South Korea | 20190017063 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2007002390 | ⤷ Subscribe |
| Russian Federation | 2683772 | ⤷ Subscribe |
| Russian Federation | 2015139553 | ⤷ Subscribe |
| Denmark | 3305302 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BIOGEN IDEC Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2548560 | C 2017 045 | Romania | ⤷ Subscribe | PRODUCT NAME: NUSINERSEN SAU SARURI ALE ACESTUIA; NATIONAL AUTHORISATION NUMBER: EU/1/17/1188; DATE OF NATIONAL AUTHORISATION: 20170530; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1188; DATE OF FIRST AUTHORISATION IN EEA: 20170530 |
| 2548560 | PA2017037,C2548560 | Lithuania | ⤷ Subscribe | PRODUCT NAME: NUSINERSENAS ARBA JO DRUSKOS; REGISTRATION NO/DATE: EU/1/17/1188/001 20170530 |
| 2548560 | LUC00046 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: NUSINERSEN OU SES SELS; AUTHORISATION NUMBER AND DATE: EU/1/17/1188 20170601 |
| 2548560 | 122017000100 | Germany | ⤷ Subscribe | PRODUCT NAME: NUSINERSEN ODER SALZE DAVON; REGISTRATION NO/DATE: EU/1/17/1188 20170530 |
| 2548560 | SPC/GB17/069 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: NUSINERSEN OR SALTS THEREOF; REGISTERED: UK EU/1/17/1188 20170601 |
| 1910395 | 132017000128668 | Italy | ⤷ Subscribe | PRODUCT NAME: NUSINERSEN O SUOI SALI(SPINRAZA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1188, 20170601 |
| 3449926 | 2020008 | Norway | ⤷ Subscribe | PRODUCT NAME: NUSINERSEN ELLER SALTER DERAV; REG. NO/DATE: EU/1/17/1188 20170608 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
